Clinical Trial Update: A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 dose-finding trial evaluating the safety, reactogenicity, and immune response of GBP511, a broadly protective sarbecovirus vaccine, in healthy adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sars

Drugs mentioned

• GBP511

Snippet

Sponsor: SK Bioscience Co., Ltd. | Conditions: Healthy Participants, Sarbecovirus | Phase 1, Phase 2 | Status: RECRUITING